Pediatrix Medical Group, Inc. (MD) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	2.0B	1.9B	2.0B	2.0B	2.0B
Cost of Revenue	1.5B	1.4B	1.6B	1.6B	1.5B
Gross Profit	506.1M	471.9M	454.3M	421.6M	467.0M
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	249.9M	240.8M	238.4M	227.5M	231.4M
General & Admin Expense	249.9M	240.8M	238.4M	227.5M	231.4M
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	32.7M	—	284.6M	186.7M	62.9M
Total Operating Expenses	282.7M	240.8M	523.1M	414.2M	294.3M
Cost and Expenses	1.7B	1.7B	2.1B	2.0B	1.8B
Operating Income (EBIT)	223.4M	231.1M	(68.7M)	7.3M	172.7M
Non-Operating
Interest Income	4.7M	19.0M	—	—	—
Interest Expense	33.3M	36.0M	40.7M	42.1M	39.7M
Net Interest Income	(28.6M)	(16.9M)	(40.7M)	(42.1M)	(39.7M)
Other Non-Op Income/Expense	(20.0M)	(14.7M)	(32.6M)	(55.7M)	(91.3M)
Non-Operating Income (excl Interest)	(2.9M)	(21.3M)	(8.1M)	13.6M	51.6M
EBT (Pre-Tax Income)	203.4M	216.4M	(101.3M)	(48.4M)	81.4M
Income Tax Expense	53.3M	51.0M	(2.3M)	12.0M	18.8M
Bottom Line
Net Income	150.1M	165.4M	(99.1M)	(60.4M)	66.3M
Earnings from Cont. Ops	150.1M	165.4M	(99.1M)	(60.4M)	62.6M
Earnings from Discont. Ops	—	—	—	—	3.8M
Bottom Line Net Income	150.1M	165.4M	(99.1M)	(60.4M)	66.3M
Per Share
Basic EPS	$1.87	$1.94	($1.19)	($0.73)	$0.80
Diluted EPS	$1.84	$1.94	($1.19)	($0.73)	$0.79
Revenue Per Share	$25.35	$22.45	$24.16	$24.27	$23.77
Shares
Basic Shares Outstanding	77.3M	85.3M	83.3M	82.2M	82.9M
Diluted Shares Outstanding	79.7M	85.3M	83.3M	82.2M	84.1M
Profitability Metrics
EBITDA	250.0M	274.2M	(28.4M)	29.9M	156.7M
D&A	23.8M	21.8M	32.2M	36.2M	35.6M
EBIT	226.2M	252.4M	(60.6M)	(6.3M)	121.1M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026